AI in Healthcare: Navigating Innovation and Consumer Protection
KFF's extensive research and analysis offer valuable insights into health policy issues and public programs, aiming to influence national conversations through surveys on Americans' perceptions of the health care system. In recent times, discussions around artificial intelligence (AI) technology have intensified, particularly concerning its potential roles in health care. The Trump administration's release of "A National Policy Framework for Artificial Intelligence" proposes legislative recommendations encouraging the adoption of AI across various sectors, including health care.
A significant aspect of this framework is its emphasis on establishing a federal AI policy that could override state laws, impacting regulations related to health coverage such as AI-driven prior authorization delays and claims reviews. In the health insurance sector, AI finds applications across several processes, including prior authorization and claims reviews. These steps evaluate coverage eligibility and determine payment decisions, respectively. Stakeholders including insurers, providers, and patients have adopted AI to enhance these procedures.
Insurers utilize AI to improve the speed and accuracy of claims processing, while providers employ AI within their revenue cycle management systems to streamline operations like coding and billing. Patients also benefit from AI tools by facilitating appeals against denied claims through improved access to health information and guidelines. The ongoing advancement in data interoperability aims to integrate electronic data sharing among health plans, providers, and patients, further optimizing these AI applications.
However, increased data sharing raises concerns about privacy risks and inappropriate data use. As AI systems evolve, there is a rising concern about the potential for biased outcomes or privacy breaches, particularly when these systems rely heavily on algorithms with little human oversight. To address these issues, several insurers have pledged that medical professionals will review prior authorization denials involving clinical issues starting in 2025. Despite the benefits, there are significant risks, such as algorithmic bias, where studies have indicated disparities in how AI models interpret data across demographics.
The Trump administration's AI framework suggests maintaining federal oversight over AI regulation, potentially sidelining state-level consumer protections. While this may streamline processes and encourage AI innovation, it also poses challenges in ensuring comprehensive consumer protection. Presently, federal standards on AI use in claims reviews are limited, with different oversight responsibilities managed by various federal agencies.
Federal guidance on AI use in Medicare and Medicaid has been minimal, highlighting the need for clear regulations to ensure fair practices. States have started to enact laws addressing AI use in health insurance, focusing on misuse protections. Insurance regulators in some states have issued guidance clarifying how existing laws apply to AI to safeguard consumer interests.
The balance between technological innovation and consumer protection remains a crucial discussion topic. AI's role in claims review and prior authorization processes must be transparent and adequately regulated to mitigate risks. Future policy developments are likely to focus on refining the interplay between federal and state regulations, determining appropriate oversight mechanisms, and evaluating AI tools' impact on cost and quality in the health care system. Concerns about data privacy, discriminatory practices, and transparency will be central to shaping upcoming legislative and regulatory initiatives in this domain.